The concentration of alpha2HS-glycoprotein (a2HS-GP), as measured by the single radial immunodiffusion technique in the sera of 52 patients with various renal diseases and varying degrees of proteinuria, was found to be significantly reduced (P<0-001) when compared to the control values. Out of the 52 patients examined, 34 were found to excrete a2HS-GP in urine with no correlation between the serum and urine levels of this protein. Although there is a statistically significant correlation between the clearances of albumin and a2HS-GP, in only six patients were the clearances of a2HS-GP within ± 25% of albumin clearance. Twelve had higher, and 16 had lower, relative clearances of a2HS-GP. The relative clearance of a2HS-GP had no relation to the serum levels of a2HS-GP, but correlated with the degree of proteinuria and the type of histological lesion in the kidney. In conclusion, there is a quantitative reduction of serum a2HS-GP in patients with renal diseases. It appears that the degree of proteinuria and the type of renal lesion influences its selective handling by the kidneys.
Introduction
Alpha2HS-glycoprotein (a2HS-GP), a normal human plasma globulin, is a negative acute-phase reactant and its concentration is altered in many unrelated disease states (Putnam, 1975; Lebreton et al., 1979; Schelp et al., 1980) including malignancy (Baskies et al., 1980) . It has been reported that a2HS-GP has some opsonic properties (Van Oss et al., 1974) and a role in the mineral phase of bone (Ashton, Hohling and Triffitt, 1976) . Its physicochemical properties and micro-heterogeneity are well documented (Gejyo and Schmid, 1981) .
In the present work, we made a preliminary investigation of the serum and urinary levels of a2HS-GP in various renal diseases with special reference to its clearance in relation to that of albumin. Urinary concentrations of total protein and fibrinogen degradation products (FDP) were also determined.
Materials and methods Patients
Fifty-two patients with renal disease (28 males and 24 females) selected randomly from the nephrology unit of the Niigata University Hospital constituted the study material. The diagnosis was based on the clinical, biochemical and histopathological examinations. Forty-seven patients had mainly glomerular diseases. Two patients had polycystic kidneys, another 2 had interstitial nephritis and one had only postural proteinuria. The proteinuria in the patients varied from a 'trace' to 14 g/litre, but the majority of them excreted more than 1 g/litre. Patients having disorders or complications known to influence the serum levels of a2HS-GP were not included in the study and all the patients had normal serum alkaline phosphatase activity.
Methods
Serum and urine samples collected from the patients were stored at -20°C. An aliquot (5 ml) of each urine sample was dialysed, lyophilised and finally reconstituted with a small volume of buffered solution to give 10-times concentrated samples. The amounts of a2HS-GP and albumin in these samples were measured by the single radial immunodiffusion technique using commercial plates (Behringwerke were purchased from the same company. Total protein and FDP in unconcentrated urine samples were quantitated by Esbach's method and latex test (Melliger, 1970) respectively. Serum total protein was measured by standard methods on an autoanalyser (Hitachi M400). Glomerular filtration rate was assessed by sodium thiosulphate clearance (CThiO) according to the method described by Newman, Gilman and Philips (1946) . Serum total protein concentration did not correlate with serum a2HS-GP (r=0-266; n=52), but correlated significantly and inversely with a2HS-GP in urine (r= -0-357; n=34; P<0 05). There was a significant correlation between the serum total protein and serum albumin (r=0-78; n=52; P<0 001). A highly significant correlation was found between a2HS-GP in urine and urinary FDP on one hand (r=0-75: n=32; P<0-001) and with urinary total protein on the other (r=0-75; n=34; P<0001). A significant correlation also existed between urinary total protein and FDP (r=54; n=32; P<0-01). No statistically significant relation could be found between the glomerular filtration rate and urinary a2HS-GP (r=0-24; n=33).
Results
Though the urinary losses of albumin and a2HS-GP (r=0.50; n=34; P<0-01) and their clearances correlated significantly (r= 068; n = 34; P<0 001), of special interest in this study was the finding of no correlation between the serum and urine levels of a2HS-GP (r= -0-04; n = 34), whereas a good correlation existed between the serum and urinary levels of albumin (r= -0 37; n = 32; P<0 05). A closer examination of the relative clearance of a2HS-GP (C-2HS-GP) (relative to that of albumin) revealed that out of the 34 patients found to excrete a2HS-GP in urine, only 18% showed comparable clearances (i.e., within ± 25% of albumin clearance, Ca1bumin), while 35% had higher and 47% had lower clearances. The relative clearance of a2HS-GP had no correlation with its serum levels (r = -0 13; n = 34), but had a correlation with its urine levels (r= -0-39; n=33; P<005). A semilog plot of CaIbumin/CU2HS GPx 100 v. proteinuria had revealed some more salient features (Fig. 1) . In Fig. 1 , each type of renal lesion can also be identified by a specific symbol and an inset is drawn to enclose such of those cases deviating markedly from a possible regression line (interrupted line). If these patients are excluded, the rest will have a statistically significant regression line at the 1% confidence level.
The possible relevance of these findings is discussed below. 
Discussion
The present work is a study of the variation in the serum and urine levels of a2HS-GP in renal diseases with emphasis on its relative clearance. From our data, it is clear that the serum concentration of a2HS-GP is reduced in renal diseases and the reduction is more prominent in certain types. The fact that the decrease in the a2HS-GP concentration in the sera of patients is not a consequence of such non-specific factors as haemodilution or decreased plasma protein synthesis is substantiated by a non-significant correlation between the serum total protein and serum a2HS-GP levels, whereas a highly significant correlation existed between serum albumin and serum total protein.
The lack of correlation between the serum and urinary levels of a2HS-GP prompted us to consider its possible tubular reabsorption. The clearance studies also supported this notion.
Alpha2HS-glycoprotein with a molecular weight of 51-56000 is smaller in size than albumin and a clearance very close to, or a little higher than that of albumin would be expected if it were not further handled by the tubules. However, the clearance data show that a considerable degree of this protein is being reabsorbed by tubules. As many as 47% of the patients had lower clearances. Although it is not possible to identify all the factors affecting the relative clearance of a2HS-GP, Fig. 1 reveals that it is influenced by the degree of proteinuria and the type of renal lesion. It is evident from the figure that there is a possible correlation between the degree of proteinuria and the relative clearance of a2HS-GP, and that patients with only certain types of lesions deviated markedly from this regression line. These deviating lesions (inset in Fig. 1 ) included interstitial nephritis, polycystic kidney, where tubules are affected, postural proteinuria, renal amyloidosis with Beh'et's disease and a few cases of lupus nephritis. Although all of these patients excreted less than 2.5 g/litre of protein, their tubular reabsorptive capacity was obviously not coping with the urinary losses of a2HS-GP, even at a comparatively low proteinuria.
The rest of the patients depicted in Fig. 1 , despite some scattering, followed a regression line that significantly correlated the relative clearance of a2HS-GP with proteinuria.
It is possible to interpret Fig. 1 in another way. As expected, patients with tubular interstitial diseases and polycystic kidneys had high relative clearances, even at comparatively low proteinuria indicating the failure of the damaged tubules to reabsorb a2HS-GP effectively. On the other hand, patients with glomerular lesions, in general, showed low relative clearances indicating effective tubular reabsorption, the exceptions being only those cases where there was massive proteinuria (>11 g/litre). These cases of glomerular lesions with massive proteinuria and high relative clearances obviously point to the saturation of tubular reabsorptive capacity and consequent 'overflow', rather than a defect in the tubules. In this context, it is noteworthy that such a type of overflow occurred only in one or two cases of glomerular lesions, only when the proteinuria was massive (more than 11 g/litre). It is an approximate measure of the tubular reabsorptive capacity for this protein.
Though how far such a pattern of relative clearance is related to the histological lesions in the kidney and to the degree of proteinuria can be debatable, it is interesting that a strong association does exist among these 3 variables in our study.
Many studies are available on proteinuria in health and renal diseases both in experimental animals and man (Weise, 1981 ). Yet our knowledge of renal handling of proteins, even in health, is not as advanced as that of the handling of low molecular weight solutes such as amino acids, sugars and electrolytes by the nephron, for which many transport systems are identified and even characterised. Our understanding of the mechanism of tubular reabsorption of proteins, even in health, is fragmentary. The situation is further complicated in diseases where glomeruli, tubules or both are affected to varying degrees. Biennenstock and Poortmans (1970) studied the renal clearances of 15 plasma proteins (excluding a2HS-GP) in 10 patients with renal diseases of mainly glomerular origin. Their results strongly suggest that in renal diseases, the handling of proteins by the nephron may be selective. They found that even proteins of similar molecular size and charge were differently handled by the kidneys in disease. They showed that 3 proteins with lower molecular weights, a,anti-trypsin (mol. wt. =45000), a2Gc-globulin (mol. wt. = 50000) and pre-albumin (mol. wt. =61000) consistently had clearances lower than that of albumin. However, in our study with a2HS-GP (mol. wt. 51-56000), we could not find such a consistent lower clearance, possibly due to the influence of the other 2 factors, namely the degree of proteinuria and the type of renal lesion as discussed above. It seems reasonable that, apart from these two factors, our observations are in accordance with the findings of Biennenstock and Poortmans and lend credence to the theory of selective clearance of proteins.
In conclusion, our study shows that the concentration of serum a2HS-GP is reduced in patients with renal diseases and its relative clearance is apparently influenced by the degree of proteinuria and the type of renal lesion.
